Money Runners

[JamesRich]

Since $RGC Regencell was listed on NASDAQ in mid-July 2021, Regencell Bioscience founder and CEO, Yat-Gai Au has made purchases of ordinary company shares from the open market to alleviate the short and distort investing schemes used on the company's stocks which in the long term can negatively hurt overall stock performance. With millions of his personal finances already spent to purchase company shares, Yat-Gai Au shared why he's fully committed to this strategy and the future of the company.